INTRODUCTION {#SEC1}
============

MicroRNAs (miRNAs), ∼22-nt small non-coding RNAs, are found in a wide range of eukaryotes and play important roles in a variety of cellular processes ([@B1]--[@B3]). MiRNA associates with Argonaute (AGO) and other proteins to form the RNA-induced silencing complex (RISC), which functions in post-transcriptional gene silencing ([@B2],[@B4]--[@B6]). The AGO protein family is a class of conserved essential molecules that are involved in diverse modes of small RNA-mediated gene silencing ([@B2],[@B7]--[@B10]). Among the mammalian AGO protein family, only AGO2 has catalytic activity for slicing. Functions of the non-catalytic members AGO1, AGO3 and AGO4 appear to be at least partially redundant ([@B11]). As a consequence of AGO2 binding, the mRNA is sliced. On the other hand, for target mRNA repression, AGO proteins directly interact with a member of the GW protein family on the target mRNA. AGO-GW182 induces mRNA deadenylation by recruiting the deadenylase CCR4--NOT complex, subsequently triggering destabilization or translational repression of target mRNAs ([@B5],[@B11],[@B12]). MiRNAs in RISC generally bind to 3΄ untranslated regions (UTRs) of target mRNAs through base-pairing via a ∼7-nt complementary 'seed' region ([@B5],[@B13]). However, it has been suggested that seed complementarity alone is not always sufficient to identify mRNA targets ([@B14]). Recent reports have revealed extensive AGO-bound mRNAs with no complementarity to miRNA seeds in AGO-crosslinking and immunoprecipitation (AGO-CLIP) experiments ([@B15]--[@B18]). Moreover, enrichment of a G-rich motif in sequences crosslinked with AGO2 was observed in the presence and absence of mature miRNAs ([@B19]). Thus, it remains unclear whether or not AGO proteins are RNA-binding proteins (RBPs) with their own specificities for mRNA sequence recognition.

RBPs critically contribute to the regulation of gene expression by affecting all aspects of RNA metabolism ([@B20]). In addition to mediating alternative splicing and polyadenylation of mRNAs, RBPs affect the stability and translation efficacy of target mRNAs, thereby controlling protein expression patterns in time and space ([@B21],[@B22]). RBPs also facilitate mRNA quality control by recruiting specialized mRNA surveillance factors and are essential for proper microtubule-dependent localization of transcripts ([@B23],[@B24]). Recent genetic, proteomic and animal model studies have suggested that RBPs may be involved in many human diseases, including cancers, neurological disorders and muscular atrophies ([@B25]--[@B28]). The functional diversity of RBPs reflects a corresponding diversity in the RNA-binding modules that are responsible for their recognition of target RNAs ([@B26],[@B29]). Recently, several groups suggested that more specific miRNA--RBP interactions may be involved in the regulating the binding of miRNAs to target RNA motifs under various physiological conditions and in response to external stimuli ([@B3],[@B30]--[@B33]). RBP binding induces local changes in the secondary structure of the mRNA 3΄UTR, creating or hiding sites for miRNA interaction and thereby modulating miRNA-mediated gene expression positively or negatively ([@B30],[@B34]--[@B36]). RNA-binding activities of RBPs can be rapidly modulated by changes in RBP abundance, subcellular localization and post-translational modifications ([@B3],[@B37]). However, we do not yet fully understand the mechanisms by which RBPs bind to target RNAs, or the consequences of such binding.

In this report, we identified *ACOT7* mRNA as a novel WIG1 target. Interestingly, our findings reveal that the AGO2--GW182 complex exists on *ACOT7* mRNA despite miRNA dysregulation due to WIG1 guidance. We also found that the translational status of *ACOT7* mRNA is suppressed through the association of WIG1 with the general translation initiation factor 5B (eIF5B).

MATERIALS AND METHODS {#SEC2}
=====================

Cell culture {#SEC2-1}
------------

MCF7 cells and HEK293T cells were grown in Dulbecco\'s modified Eagle\'s medium (WelGENE, Daegu, Korea). DICER knockout (−/−) HCT116 cell line, which was developed by Kim *et al*. ([@B38]), was purchased from the Korean Collection for Type Cultures (KCTC), Korea Research institute of Bioscience and Biotechnology (KRIBB), Korea. HCT116 parent cells and DICER knockout (−/−) HCT116 cell lines were grown in McCoy\'s 5A medium (WelGENE). Cells were cultured with 10% Fetal Bovine Serum (Lonza Group Ltd., Basel, Switzerland) and 1% penicillin and streptomycin solution (WelGENE) at 37°C in a 5% CO~2~ incubator.

Immunoprecipitation and biotin pulldown {#SEC2-2}
---------------------------------------

Immunoprecipitation was performed as described previously ([@B36]). Briefly, Con Si- and WIG1 Si-transfected MCF7 cells were transfected with biotin-miR-9 or -miR-101 (Bioneer Inc., Daejeon, Korea) for streptavidin pulldown. After 2 days, harvested cells were rinsed and sonicated in NET-2 buffer. Yeast tRNA-coated streptavidin beads (Sigma-Aldrich, St Louis, MO, USA) were used to collect the biotinyl-miRNAs, and bead-bound RNAs were amplified using RT-sqPCR.

Biotinylated DNA probe-RNA hybridization and pulldown assay {#SEC2-3}
-----------------------------------------------------------

Biotinylated DNA probe-RNA hybridization and biotinylation-streptavidin precipitation assay were performed with some modifications as previously described ([@B39]). Briefly, p3xFlag-WIG1 and pCK-Flag-AGO2-transfected MCF7 cells were transfected with pcFLuc or pcFLuc-ACOT7-3΄UTR-Wt or pcFLuc-ACOT7-3΄UTR-Mut. After 2 days, harvested cells were rinsed and sonicated in NET-2 buffer. Biotinyl-DNA probe and yeast tRNA-coated streptavidin beads (Sigma-Aldrich) were used to collect miRNAs, and collected miRNAs in precipitates were amplified using RT-sqPCR.

Plasmid construction {#SEC2-4}
--------------------

Construction details for p3xFlag-WIG1, pCK-Flag-AGO2 and pCMV-Myc-WIG1 were previously reported ([@B36]). pcFLuc-EV was generated with ligation of HindIII/XbaI-digested pGL2-basic (Promega Corp., Madison, WI, USA) fragment into pcDNA3 (Invitrogen Corp., Carlsbad, CA, USA). pcFLuc-ACOT7-3΄UTR-Wt or -Mut plasmids were constructed with ligation of XbaI-digested fragments containing *ACOT7* 3΄UTR (NM_007274) or mutated miR-9-binding sites (^172^C → A, ^176^G→ Δ) using gBlock (IDT Corp., Coralville, IA, USA) into pcFLuc plasmid. pcFLuc-MS2BS-ACOT7-3΄UTR-Wt or -Mut plasmids were constructed with ligation of BglII/XhoI-digested polymerase chain reaction (PCR) fragment amplified from plasmid pcFLuc-ACOT7-3΄UTR (Korea Human Gene Bank, Daejeon, Korea) using primers listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"} into BglII/XhoI fragments of pcFLuc-ACOT7-3΄UTR-Wt or -Mut. To generate pMS2-HA plasmid, NheI/HindIII-digested pEGFP-C1 (Clontech Laboratories, Inc., Mountain view, CA, USA) was ligated with a NheI/HindIII fragment containing MS2-HA sequences using gBlock (IDT Corp.).

To construct pFL-ACOT7-3**΄**UTR-Wt or -Mut, pFL plasmid was inserted into an XbaI-digested pcFLuc-ACOT7-3΄UTR-Wt or -Mut fragment, respectively. To generate pCrPV-FL-ACOT7-3΄UTR-Wt or -Mut, HindIII fragment of pFL-ACOT7-3΄UTR-Wt or -Mut was ligated with a HindIII/EcoRI-digested PCR fragment amplified from php/CrPV/R-Gl plasmid and an EcoRI/HindIII-digested PCR fragment amplified from pFL-ACOT7-3΄UTR-Wt or -Mut plasmid using primers listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. To construct pEMCV-FL-ACOT7-3΄UTR-Wt or -Mut, pCrPV-FL-ACOT7-3**΄**UTR-Wt or -Mut was digested with BglII/EcoRI and ligated with a BglII/EcoRI-digested PCR fragment amplified from plasmid php/EMCV/R-Gl using primers listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.

To construct ACOT7-3΄UTR-BS Mut constructs, XbaI-digested fragments using gBlock (IDT Corp.) lacking putative WIG1-binding sites from the photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) analysis were inserted into pcFLuc or pFL plasmid. pFL-8BS construct containing 8-repeated MS2 protein-binding sites, php/EMCV/R-Gl and php/CrPV/R-Gl were kindly provided by Dr Lynne E. Maquat at University of Rochester, Rochester, NY, USA ([@B40],[@B41]). pIRES-Flag/HA-GFP, -AGO2 and -AGO2 PAZ9 were kindly provided by Dr Sven Diederichs at the German Cancer Research Center (DKFZ) ([@B42]).

RNA interference and plasmid transfection {#SEC2-5}
-----------------------------------------

Cells were transiently transfected with the indicated plasmids, 100 nM *in vitro*-synthesized siRNAs (Bioneer Inc.) or miRNA mimetics (Bioneer Inc.), using either Lipofectamine 2000 (Invitrogen) or RNAi-MAX (Invitrogen) according to the manufacturer\'s instructions. The Con-, WIG1 (or WIG1 \#1), WIG1 \#2, WIG1 \#3 and AGO2 (or AGO2-\#1) specific siRNA (Si) sequences and anti-miR-106b sequences were used as described previously ([@B36]). AGO1, AGO2 \#2, AGO2 \#3, AGO3, AGO4, DICER (or DICER \#1), DICER \#2, DICER \#3 and GW182 specific siRNA sequences used in this study were 5'-r(GAGAAGAGGUGCUCAAGAA)(dTdT)-3', 5'-r(GCACGGAAGUCCAUCUGAA)(dTdT)-3', 5'-r(UAAUACAUCUUUGUCCUGC)(dTdT)-3', 5'-r(GAAAUUAGCAGAUUGGUAA)(dTdT)-3', 5'-r(GGCCAGAACUAAUAGCAAU)(dTdT)-3', 5'-r(UAAAGUAGCUGGAAUGAUG)(dTdT)-3', 5'-r(UGCUUGAAGCAGCUCUGGA)(dTdT)-3', 5'-r(GGAAGAGGCUGACUAUGAA)(dTdT)-3' and 5'-r(UAGCGGACCAGACAUUUCU)(dTdT)-3', respectively.

The miR-9-5p mimetic, miR-141-3p mimetic, miR-200a-3p mimetic, miR-101-3p mimetic, miR-142-3p mimetic, miR-Control, anti-miR-Control and anti-miR-9-5p sequences were 5'-r(UCUUUGGUUAUCUAGCUGUAUGA)-3', 5'-r(UAACACUGUCUGGUAAAGAUGG)-3', 5'-r(UAACACUGUCUGGUAACGAUGU)-3', 5'-r(UACAGUACUGUGAUAACUGAA)-3', 5'-r(UGUAGUGUUUCCUACUUUAUGGA)-3', 5'-r(CCUACGCCACCAAUUUCGU)-3', 2-methyl-O-labeled 5'-r(CCUACGCCACCAAUUUCGU)-3' and 2-methyl-O-labeled 5'-r(UCAUACAGCUAGAUAACCAAAGA)-3', respectively. After transfection, cells were collected and total protein and RNA were prepared for analysis.

Reverse transcription (RT) followed by semi-quantitative (sq)PCR or real-time, quantitative (q)PCR analysis {#SEC2-6}
-----------------------------------------------------------------------------------------------------------

RT-sqPCR analysis was performed as described previously ([@B36]). Total RNA was isolated from cells using TRIzol reagent (Invitrogen); after reverse transcription (RT), PCR was performed using gene-specific primers (see below) and α-\[^32^P\]-dNTP (Perkin-Elmer NEN, Wellesley, MA, USA). Radioisotope-labeled PCR products were separated on 5% polyacrylamide gels and quantified using the Quantity One software package (Bio-Rad Laboratories, Hercules, CA, USA). A standard curve of intensity versus RNA quantity was generated by 2-fold serial dilutions of purified RNAs, and relative amounts of radioisotope-labeled PCR products were determined from the standard curve. RT-qPCR was performed using DNA Engine Thermal Cycler with a Chromo4 Real-time PCR Detector (Bio-Rad Laboratories) and the following mRNA-specific primers: for ACOT7, 5'-CTGCACCCTGCACGGCTTTG-3' (sense) and 5'-CGGAAGCTGTGACGATGTTG-3' (antisense) or 5'-TCTCCCATGTGCATCGGTG-3' (sense) and 5'-TTTTCGGACATCACGTTGACC-3' (antisense); for ANKRD11, 5'-CCAACAACGGGCACTACAAG-3' (sense) and 5'-CGTCTTCCTCTTCTGAGCTC-3' (antisense); and for actin, 5'-CAAGAGATGGCCACGGCT-3' (sense) and 5'-TCCTTCTGCATCCTGTCGGC-3' (antisense). Actin served as a negative or loading control. Primers for detection of FL were 5'-AATACGACTCACTATAGGCA-3' (sense) and 5'-TCACTCTAGAGGATAGAATC-3' (antisense); FL, 5'-CAACACCCCAACATCTTCG-3' (sense) and 5'-CTTTCCGCCCTTCTTGGCC-3' (antisense); and for RL, 5'-TGA TCCAGAACAAAGGAAAC-3' (sense) and 5'-CTTATCTTGATGCTCATAGC-3' (antisense). RL served as a negative or loading control.

Photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) analysis {#SEC2-7}
-------------------------------------------------------------------------------------------------

PAR-CLIP was performed with some modifications as previously described ([@B43]). Briefly, Flag-WIG1 was expressed in HEK 293T cells. Cells were incubated in medium supplemented with 100 mM 4SU for 16 h. Cells were crosslinked by ultraviolet light at 365 nm in a Spectrolinker XL-1500 UV crosslinker. After cells were sonicated and treated with 1 U/ml of RNase T1 (Fermentas, Burlington, Canada), Flag-WIG1 was immunoprecipitated with monoclonal anti-FLAG antibodies (M2, Sigma-Aldrich) bound to Protein G-conjugated Agarose. RNA residing in the immunoprecipitate was further trimmed with 100 U/ml of RNase T1. Beads were washed in lysis buffer and resuspended in one bead volume of dephosphorylation buffer. RNA was dephosphorylated and radioactively labeled with \[γ-^32^P\]-ATP using poly-nucleotide kinase. The protein--RNA complexes were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis, after which migrating radioactive bands were transferred to a NC membrane. Protein was subjected to western blotting or removed by digestion in proteinase K buffer in the presence of 1 mg/ml of proteinase K (Sigma-Aldrich). RNA was extracted by using Trizol (Invitrogen), converted into a cDNA library and sequenced using an Illumina platform. Adapters were removed, and the processed reads were aligned to the reference genome (GRCh37/hg19) by the Bowtie algorithm (1.1.2), allowing for two alignment errors (mutation, insertion or deletion). For analysis, PARalyzer settings were set to require a minimum of five sequence reads per group and no non-conversion mismatches per sequence read after masking for repeat elements using RepeatMasker. A PARalyzer-defined group was considered as a binding site only if it had a T-to-C mutation rate of 0.25, contained more than five sequence reads with T-to-C conversions and had two or more distinct crosslinking sites. The groups and clusters were annotated with hg19 Ensembl v72 database. To approximate binding intensity using crosslinked read frequencies, raw sequence reads (rather than non-redundant sequence reads) were counted. The problem of PCR amplification bias was avoided by limiting the number of PCR cycles used for cDNA amplification to stay within the exponential amplification phase of the PCR reaction.

RESULTS {#SEC3}
=======

WIG1 is critical to regulation of ACOT7 mRNA level via miR-9-mediated mRNA decay {#SEC3-1}
--------------------------------------------------------------------------------

In a previous work, we demonstrated that WIG1 binds to *p21* (*CDKN1A*) mRNA and facilitates RISC recruitment to degrade *p21* mRNA ([@B36]). In this work, we identified additional WIG1 target mRNAs by ribonucleoprotein immunoprecipitation (RIP) and microarray analysis (RIP-chip; [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Among the list of putative WIG1 target mRNAs, we confirmed physical interaction between WIG1 and *ACOT7* mRNA using RIP and RT followed by semiquantitative polymerase chain reaction (sqPCR) (Figure [1A](#F1){ref-type="fig"}). Specificity of the RIP experiment was confirmed by negative and positive controls ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Depletion and overexpression of WIG1 increased and decreased *ACOT7* mRNA and ACOT7 protein levels, respectively (Figure [1B](#F1){ref-type="fig"}).

![WIG1 regulates *ACOT7* mRNA levels via miR-9-mediated mRNA decay. (**A**) Association of WIG1 with *ACOT7* mRNA. MCF7 cells were harvested 2 days after transfection with p3xFlag-WIG1, and RIP analysis was performed using an anti-Flag M2 affinity gel. Immunoprecipitated proteins were subjected to immunoblotting using an anti-Flag antibody (top); RNAs were radiolabeled by RT-PCR using ACOT7-specific primers (bottom), and band intensities were quantified using Quantity One software. The four leftmost lanes represent 2-fold serial dilutions of RNA and confirm that RT-PCR was semi-quantitative. Data are expressed as the means ± SD from three independent experiments. (**B**) Effects of WIG1 depletion on *ACOT7* mRNA and protein levels. MCF7 cells were transfected with WIG1 Si, and qRT-PCR and western blotting analyses were performed. Ectopic expression of WIG1 downregulates *ACOT7* mRNA and protein levels. MCF7 cells transfected with p3xFlag-WIG1 construct were harvested and analyzed as described in the left panel. (**C**) Binding of AGO2 to *ACOT7* mRNA in a WIG1-dependent manner. HEK 293T cells were harvested 2 days after transfection with either WIG1 or AGO2 Si, after which an RNP-IP assay was performed using anti-AGO2 or anti-WIG1 antibody, respectively. Immunoprecipitated proteins were subjected to immunoblotting using anti-AGO2 and anti-WIG1 antibody (left). Isolated RNAs were performed with qRT-PCR for quantification of *ACOT7* mRNA levels (right). *Actin* mRNA and protein were used as a negative or normalized control. (**D**) Effects of miR-9 on *ACOT7* mRNA and ACOT7 protein levels in WIG1-depleted MCF7 cells. Cell lysates were prepared 2 days after transfection of miR-9 into WIG1 Si-transfected cells and subjected to western blot analysis (top). RNAs were isolated, and RT-qPCR analysis was used to quantify *ACOT7* mRNA levels (bottom). (**E**) Effects of miR-9 on *ACOT7* mRNA and protein levels in WIG1-overexpressing MCF7 cells. p3xFlag-WIG1 plasmids were transfected into miR-9-transfected cells; 2 days later, protein levels were assessed by immunoblot analysis (top) and *ACOT7* mRNA levels by RT-qPCR analysis (bottom). (**F**) WIG1-dependent binding of miR-9 to *ACOT7* mRNA. Cell lysates were harvested and pulled-down with streptavidin beads 2 days after transfection with biotin-miR-9 in WIG1-depleted HEK 293T cells. Pulled-down RNA was amplified by RT-sqPCR using ACOT7-specific primers and quantified. *Actin* mRNA levels served as internal controls. The four leftmost lanes represent sequential 2-fold dilutions of RNA. Data are expressed as the means ± SD from three independent experiments. (**G**) Presence of miR-9 on target *ACOT7* mRNA under WIG1-overexpressing conditions. Cell lysates were harvested and precipitated with streptavidin beads 2 days after transfection with biotin-miR-9 in WIG1-overexpressing HEK 293T cells. Precipitated RNAs were analyzed as described in panel F. \**P* \< 0.05; \*\**P* \< 0.01; ^\#^*P* \> 0.05.](gkx307fig1){#F1}

Next, we determined whether or not binding of AGO2 to *ACOT7* mRNA is dependent on WIG1 and vice versa in WIG1- and AGO2-depleted cells. While binding of AGO2 to *ACOT7* mRNA was found to be dependent on WIG1, binding of WIG1 to *ACOT7* mRNA was not dependent on AGO2 (Figure [1C](#F1){ref-type="fig"}). We identified miR-9-5p, miR-141-3p and miR-200a-3p as microRNAs putatively interacting with *ACOT7* 3΄UTR (<http://www.targetscan.org> v7.0; [Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). Among them, miR-9-5p (hereafter miR-9) was highly expressed compared to miR-141-3p or miR-200a-3p and showed high affinity for *ACOT7* mRNA, which required the presence of WIG1 ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}). Transfection of the miR-9 mimic alone lowered *ACOT7* mRNA and protein levels (Figure [1D](#F1){ref-type="fig"}). WIG1 depletion abrogated miR-9-induced reduction of *ACOT7* mRNA and protein levels (Figure [1D](#F1){ref-type="fig"}). No off-target effects of three independent WIG1 Si at lower concentration were observed ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). In WIG1-overexpressing cells, transfection of miR-9 further reduced *ACOT7* mRNA and protein levels compared to miR-Control (Con)-transfected cells (Figure [1E](#F1){ref-type="fig"}). WIG1 overexpression promoted suppression of *ACOT7* mRNA and protein levels by miR-9 (Figure [1E](#F1){ref-type="fig"}). In addition, we observed a synergistic effect of WIG1 and AGO2 co-overexpression on ACOT7 mRNA and protein levels ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).

To further characterize this interaction, biotinylated miR-9 mimic and streptavidin-conjugated beads were used to pulldown miR-9-interacting mRNAs from WIG1-depleted and WIG1-overexpressing cells. As shown, *ACOT7* mRNA was detected by RT-sqPCR analysis of the pulldown material (Figure [1F](#F1){ref-type="fig"} and [G](#F1){ref-type="fig"}). Importantly, *ACOT7* mRNA failed to precipitate with miR-9 in the absence of WIG1 (Figure [1F](#F1){ref-type="fig"}), whereas it was highly abundant in biotin-miR-9 pulldowns using lysates from WIG1-overexpressing cells (Figure [1G](#F1){ref-type="fig"}). *ANKRD11* mRNA, an additional putative target of WIG1 ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}), was also validated ([Supplementary Figures S1 and 5](#sup1){ref-type="supplementary-material"}). As shown, WIG1 contributed to regulation of *ANKRD11* mRNA levels by mediating target-specific binding of miRNAs miR-142-3p or miR-101-3p, ultimately leading to miRNA-mediated decay of *ANKRD11* mRNA ([Supplementary Figure S5D--F](#sup1){ref-type="supplementary-material"}). These results demonstrate that WIG1 is essential for regulation of the levels of target transcripts *ACOT7* and *ANKRD11* through miRNA-mediated mRNA decay.

WIG1 binds to ACOT7 mRNA 3΄UTR and recruits AGO2 under miRNA deficiency {#SEC3-2}
-----------------------------------------------------------------------

It is generally accepted that miRNAs mediate binding between AGO2 and complementary sequences in target mRNAs ([@B2],[@B5],[@B8],[@B9],[@B11]). Thus, we investigated whether or not the interaction of WIG1--AGO2 with *ACOT7* mRNA depends on miRNA and target complementary sequences. First, we examined binding of the WIG1--AGO2 complex to *ACOT7* mRNA after anti-miR-9 transfection (Figure [2A](#F2){ref-type="fig"}). We previously demonstrated that WIG1 directly associates with AGO2 ([@B36]) and the WIG1--AGO2 complex bound to *ACOT7* mRNA target in the absence of miR-9 (Figure [2A](#F2){ref-type="fig"}). After DICER silencing, we confirmed disruption of the DICER-dependent miRNA maturation pathway using positive and negative control miRNAs ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}). We observed comparable interaction of WIG1--AGO2 with *ACOT7* mRNA in both Con siRNA (Si)- and DICER Si-transfected cells (Figure [2B](#F2){ref-type="fig"}), suggesting that microRNAs were dispensable for WIG1 binding to *ACOT7* mRNA.

![Inhibition of miRNA processing and disruption of ACOT7-3΄UTR miR-9-binding site are not sufficient to block AGO2-WIG1 binding to *ACOT7* mRNA. (**A**) Effect of anti-miR-9-5p on AGO2-WIG1 binding to *ACOT7* mRNA. HEK 293T cell lysates were harvested and precipitated with anti-Flag antibody 2 days after co-transfection of pCK-Flag-AGO2 and pCMV-Myc-WIG1 plasmids in combination with anti-miR-9. From RNP-IP, precipitated proteins were subjected to Western blotting (top). RNAs in precipitates were radiolabeled with RT-PCR using ACOT7-specific primers (bottom). *Actin* mRNA served as a negative control. Band intensity was quantified using Quantity One software. The four leftmost lanes represent 2-fold serial dilutions of RNA, and confirm RT-PCR was semi-quantitative. Relative level of miR-9 in anti-miR-9-treated cells was normalized to that of a *5S* rRNA internal control, relative to anti-miR-Con. Fold enrichment of miR-9 in Flag-AGO2 immunoprecipitates was assessed after treatment with anti-miR-9, relative to anti-miR-Con. Data are presented as means ± SD from three independent experiments. (**B**) Binding of AGO2-WIG1 to *ACOT7* mRNA in DICER-silenced cells. Immunoprecipitation was performed with anti-Flag antibody 2 days after co-transfection of pCK-Flag-AGO2 and pCMV-Myc-WIG1 in DICER Si-transfected HEK 293T cells. Precipitated proteins were subjected to western blotting (top). RNAs in precipitates were subjected to RT-PCR using *ACOT7* mRNA-specific primers (bottom). Relative level of miR-9 in DICER-treated cells was normalized to that of a *5S* rRNA internal control, relative to anti-miR-Con. Fold enrichment of miR-9 in Flag-AGO2 immunoprecipitates was assessed after treatment with DICER Si, relative to anti-miR-Con. Data are presented as means ± SD from three independent experiments. \**P* \< 0.05; \*\**P* \< 0.01; ^\#^*P* \> 0.05.](gkx307fig2){#F2}

To further study this possibility, we tested a mutant (Mut) luciferase reporter construct bearing disruption of the miR-9 seed region within the full-length *ACOT7* 3΄UTR (pcFLuc-ACOT7-3΄UTR-Mut; Figure [3A](#F3){ref-type="fig"}). In contrast to changes in the level of wild-type (Wt) *ACOT7* 3΄UTR reporter mRNA after WIG1 depletion, *ACOT7* 3΄UTR Mut reporter mRNA was not responsive to alterations in the levels of WIG1 or miR-9 (Figure [3B](#F3){ref-type="fig"}, left). We observed similar changes in reporter mRNA levels in WIG1-overexpressing cells (Figure [3B](#F3){ref-type="fig"}, right). In addition, we observed that the WIG1--AGO2 complex bound to both *ACOT7 3*΄*UTR Wt* mRNA and *ACOT7 3*΄*UTR Mut* mRNA in both Con Si- and DICER Si-transfected cells (Figure [3C](#F3){ref-type="fig"}). These results further indicate that the WIG1--AGO2 complex was capable of binding to the *ACOT7* 3΄UTR in the absence of miR-9 or after disrupting the miR-9 complementary sequence. However, the possibility remains that other miRNAs could guide AGO2 through DICER-independent miRNA biogenesis ([@B44],[@B45]). To test this possibility, we transfected AGO2 PAZ9 mutant, which contains nine point mutations within the AGO2 PAZ domain ([@B42],[@B46]--[@B48]). Although AGO2 PAZ9 mutant showed reduced interactions with miRNAs (Figure [3D](#F3){ref-type="fig"}, right), the WIG1--AGO2 PAZ9 complex was capable of binding to the *ACOT7* 3΄UTR (Figure [3D](#F3){ref-type="fig"}, left) without changes in miR-9 levels (Figure [3D](#F3){ref-type="fig"}, middle). Altogether, these results indicate that WIG1 is indispensable for AGO2 binding to the *ACOT7* 3΄UTR, regardless of the miRNA loading ability of AGO2 or the presence of miRNA complementary sequence on the mRNA.

![WIG1 binds to *ACOT7* mRNA 3΄UTR and recruits AGO2 despite disruption of miR-9 site, inhibition of miRNA synthesis or loss of miRNA. (**A**) Cloning strategy for disrupting miR-9 target sequence on ACOT7 3'UTR with stem loops as predicted by RNAfold software. ACOT7 3΄UTR containing one substitution (^172^C → A) and one deletion (^176^G → Δ) in miR-9 target site was cloned into pcFLuc-empty vector (EV); Wt, wild-type; Mut, mutant. pcFLuc-EV was used as control. Base-pair probability is color-coded. (**B**) Effect of miR-9 on ACOT7-3΄UTR-Wt and -Mut reporters after modulation of WIG1 levels. Cells were transfected with either WIG1 Si or p3xFlag-WIG1 (Flag-Wig), followed by either pcFLuc-ACOT7-3΄UTR-Wt or -Mut in combination with miR-9. pRL-CMV was used as a reference plasmid. RNAs were isolated 2 days after transfection and measured by RT-qPCR analysis. *FL* mRNA levels were normalized to those expressed from *pcFLuc-EV* mRNA; RT-PCR intensities represent the means ± SD from three independent experiments. (**C**) Binding of AGO2 to ACOT7 3**΄**UTR containing mutations in miR-9 target sites. HEK 293T cells were transfected with DICER Si and then transfected with either pcFLuc-ACOT7-3΄UTR-Wt or -Mut reporter plasmids, pCK-Flag-AGO2 and pCMV-Myc-WIG1 in combination with pRL-CMV reference plasmid. Left, following RIP, precipitated proteins were assessed by western blot analysis to identify the indicated proteins (top), RNAs were radiolabeled using RT-PCR with *FL* and *RL* mRNA-specific primers and band intensities were quantified using Quantity One software (bottom). The four leftmost lanes represent sequential 2-fold dilutions of RNA. Left, miR-9 levels in Flag-AGO2 immunoprecipitates, as assessed by RT-qPCR analysis using pcFLuc-ACOT7-3΄UTR-Wt and -Mut reporters. Data represent the means ± SD from three independent experiments. (**D**) MicroRNA binding-defective AGO2 PAZ9 mutant binds to *ACOT7* mRNA in the presence of WIG1. HEK 293T cells were transfected with pcFLuc-ACOT7-3΄UTR-Wt in combination with either pIRES-Flag/HA-AGO2 or -AGO2 PAZ9, after which RIP was performed using anti-Flag antibody. Precipitated proteins were assessed by western blot analysis (top), and precipitated RNAs were assessed by RT-qPCR analysis (bottom). pRL-CMV was used as a negative control for IP efficiency. Levels of miRNAs extracted from pre-immune lysates (Before IP) or immunoprecipitates (After IP) were assessed by RT-qPCR (right). Data represent the means ± SD from three independent experiments. \**P* \< 0.05; \*\**P* \< 0.01; ^\#^*P* \> 0.05.](gkx307fig3){#F3}

WIG1 suppresses translational initiation through the association of WIG1--AGO2--GW182 complex with eIF5B {#SEC3-3}
--------------------------------------------------------------------------------------------------------

Since the WIG1--AGO2 complex was shown to be capable of binding to the *ACOT7* 3΄UTR independent of miRNA, we examined the role of the WIG1--AGO2 complex in gene silencing under such conditions. After transfection of either pFL-ACOT7-3΄UTR-Wt or pFL-ACOT7-3΄UTR-Mut, we calculated translational efficiency using dual luciferase assay and RT-qPCR detection of *RL* and *FL* mRNAs (Figure [4A](#F4){ref-type="fig"}). Translation was enhanced with increasing levels of *FL-ACOT7-3΄UTR-Wt* mRNA in the absence of miR-9 (Figure [4A](#F4){ref-type="fig"}, right). It was further enhanced when either WIG1 or AGO2 was additionally depleted in the absence of miR-9 (Figure [4A](#F4){ref-type="fig"}, right), although there was no change in *FL-ACOT7-3΄UTR-Wt* mRNA level (Figure [4A](#F4){ref-type="fig"}, left). Consistent results were observed when we examined endogenous ACOT7 mRNA and protein levels under the same conditions (Figure [4B](#F4){ref-type="fig"}). In pFL-ACOT7-3΄UTR-Mut-transfected cells, translational efficiencies were enhanced in the absence of either WIG1 or AGO2 (Figure [4C](#F4){ref-type="fig"}, right) with no change in reporter mRNA levels (Figure [4C](#F4){ref-type="fig"}, left).

![WIG1 tethering suppresses ACOT7 protein synthesis in AGO2-GW182 dependency. (**A**) Relative translational efficiency of ACOT7 3΄UTR reporters in the presence of anti-miR-9 in WIG1- or AGO2-depleted cells. MCF7 cells were transfected with either WIG1 Si or AGO2 Si as well as with pFL-ACOT7-3΄UTR-Wt and anti-miR-9 in combination with reference plasmid pRL-CMV. Cells were harvested 2 days after transfection, and *FL* and *RL* mRNAs were quantified using RT-qPCR. *FL* mRNA levels were normalized to *RL* mRNA levels (left). Translation rates were determined as the ratios of FL protein (luciferase activity, normalized to RL) to *FL* mRNA (normalized to *RL* mRNA). (**B**) Endogenous ACOT7 mRNA and protein levels in the presence of anti-miR-9 in WIG1- or AGO2-depleted cells. Lysates were prepared as explained in Figure [4A](#F4){ref-type="fig"}, followed by western blot analysis. Total RNA was subjected by qRT-PCR using ACOT7-specific primers. Actin was used as a loading control. (**C**) MCF7 cells were transfected with either WIG1 Si or AGO2 Si in combination with pFL-ACOT7-3**΄**UTR-Mut and pRL-CMV reference plasmid. *FL* mRNA levels and translation rates were determined as explained in panel A. (**D**) Diagrams of reporter vectors encoding *ACOT7* mRNA 3΄UTR-Wt and -Mut with three copies of MS2-binding site (BS): pcFLuc-MS2BS-ACOT7-3΄UTR-Wt and -Mut. pcFLuc-EV was used as a reference control. (**E**) WIG1-dependent recruitment of AGO2-GW182 to 3΄UTR of *ACOT7* mRNA in the absence of miRNA processing. HEK 293T cells were transfected with DICER Si and WIG1 Si and pcFLuc-MS2BS-ACOT7-3΄UTR-Wt reporter plasmid in combination with pCK-Flag-AGO2 and pMS2-HA. Cells were harvested 2 days after transfection and subjected to IP and western blot analysis to detect the indicated proteins. (**F**) Diagrams of MS2-HA-WIG1 reporter vector encoding FL coding region with eight copies of MS2-binding site (BS). (**G**) MCF7 cells were transfected either AGO2 Si or GW182 Si, followed by pFL-8BS, pMS2-HA and pMS2-HA-WIG1 in combination with pRL-CMV reference plasmid. Cells were harvested 2 days after transfection, followed by western blot analysis. Reporter RNA levels and translation rates were determined as explained in panel A. Data are presented as means ± SD from three independent experiments. \**P* \< 0.05; \*\**P* \< 0.01; ^\#^*P* \> 0.05.](gkx307fig4){#F4}

We next investigated whether or not WIG1 helps recruit another RISC component, GW182, to the target mRNA regardless of miRNA loading capability. We co-transfected a reporter plasmid and an effector plasmid. Reporter plasmid encodes either FLuc-MS2BS-ACOT7-3΄UTR-Wt or -Mut, which expresses three copies of the MS2 coat protein-binding site (MS2BS) downstream of the reporter STOP codon (Figure [4D](#F4){ref-type="fig"}). An effector plasmid produces MS2-HA, which expresses the bacteriophage MS2 coat protein tagged with the polypeptide HA ([@B40]). When we measured relative reporter mRNA levels with these constructs in the presence and absence of WIG1, reporter mRNAs were destabilized in WIG1- and miRNA-dependent manners ([Supplementary Figure S7A](#sup1){ref-type="supplementary-material"}). Endogenous GW182 associated with the WIG1--AGO2 complex on the *ACOT7*-3΄UTR when miRNA biogenesis was impaired (DICER Si) and in the absence of miRNA complementary sequence (FLuc-MS2BS-ACOT7-3΄UTR-Mut) ([Supplementary Figure S7B](#sup1){ref-type="supplementary-material"}).

It is generally believed that mammalian miRNAs guide the RISC to target mRNAs through the seed-pairing rule ([@B18]). However, recent reports have demonstrated that members of the AGO family of proteins directly associate with mRNAs lacking seed complementarity with miRNAs ([@B18],[@B49]--[@B51]). We observed that AGO2 had a direct binding preference for the *ACOT7* 3΄UTR, which was dependent on the presence of WIG1 but not miRNAs (Figure [4E](#F4){ref-type="fig"}); GW182 was also detected in WIG1-dependent and miRNA-independent manners (Figure [4E](#F4){ref-type="fig"}). Whereas WIG1 still bound to *ACOT7* 3**΄**UTR in AGO2-depleted cells, GW182 was not present in the immunoprecipitates ([Supplementary Figure S7C](#sup1){ref-type="supplementary-material"}). Together, these data further support the view that recruitment of AGO2 to target *ACOT7* mRNA is dependent on WIG1 but not miRNAs. Furthermore, GW182 associated with AGO2 on target *ACOT7* mRNA in the presence and absence of miRNAs in a WIG1-dependent manner (Figure [4E](#F4){ref-type="fig"}). No off-target effect of DICER Si was observed, as shown in [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}. In a previous report, we demonstrated that *p21* mRNA is a novel target of the WIG1--AGO complex ([@B36]). Here, WIG1 was found to be involved in translational suppression of *p21* mRNA independently of miR-106b ([Supplementary Figure S9A](#sup1){ref-type="supplementary-material"}).

To assess the combined effects of WIG1, AGO2 and GW182 on translational suppression, we generated a MS2-HA-WIG1 tethering construct on pFL-8BS reporter mRNA containing the full-length firefly luciferase (FL) coding region and MS2 protein-binding sites beyond the terminal codon (Figure [4F](#F4){ref-type="fig"}). Fusion protein levels in cells transfected with pMS2-HA-WIG1 were detected by Western blot analysis (Figure [4G](#F4){ref-type="fig"}). MS2-HA-WIG1 reduced the efficiency of translation from *FL-8BS* mRNA (Figure [4G](#F4){ref-type="fig"}, right, lane 1 versus 2) without altering mRNA levels (Figure [4G](#F4){ref-type="fig"}, left). Since GW182 interacts with AGO proteins via a specific AGO-interaction domain ([@B6],[@B52]--[@B55]), we hypothesized that the tethered WIG1 might also require recruitment of GW182. Thus, we examined the extent of translational repression by tethered WIG1 upon depletion of either AGO2 or GW182 (Figure [4G](#F4){ref-type="fig"} and [Supplementary Figure S9B](#sup1){ref-type="supplementary-material"}); as shown, depletion of either AGO2 or GW182 rescued loss of translational efficiency mediated by tethered WIG1 (Figure [4G](#F4){ref-type="fig"}, right, lane 3 versus 4 and lane 5 versus 6). No off-target effect of AGO2 Si was observed, as shown in [Supplementary Figure S10](#sup1){ref-type="supplementary-material"}. In the absence of WIG1, AGO2--GW182 complex was not found in the *ACOT7* 3'UTR ([Supplementary Figure S11A](#sup1){ref-type="supplementary-material"}). However, AGO2--GW182 interaction was still observed in the absence of endogenous WIG1 ([Supplementary Figure S11B](#sup1){ref-type="supplementary-material"}). These data are consistent with a model whereby WIG1 recruits AGO2--GW182 to a target mRNA through direct interaction between WIG1 and AGO2 in an miRNA-independent manner, resulting in translational suppression.

We additionally examined whether or not WIG1 could interact with other human AGO proteins. AGO1 was detectable with GW182 in WIG1 immunoprecipitates ([Supplementary Figure S12A](#sup1){ref-type="supplementary-material"}). The AGO1--GW182 complex was not found on the *ACOT7* 3'UTR in the absence of WIG1 ([Supplementary Figure S11A](#sup1){ref-type="supplementary-material"}). However, AGO1-GW182 interaction *per se* was present in the absence of endogenous WIG1, as previously shown with AGO2 ([Supplementary Figure S11B](#sup1){ref-type="supplementary-material"}). In addition, GW182 was barely detectable on the *ACOT7* 3'UTR in either AGO1- or AGO2-depleted cells ([Supplementary Figure S12B](#sup1){ref-type="supplementary-material"}). In contrast to AGO2, AGO1 depletion affected the ACOT7 protein level but not mRNA level and deadenylation ([Supplementary Figure S12C and D](#sup1){ref-type="supplementary-material"}). From these results, we suggest that AGO1 and AGO2 might play different roles in the regulation of target gene expression with WIG1 dependency.

We further demonstrated the combined effect of WIG1, AGO1/2 and GW182 on translational suppression in human DICER −/− cells developed by Kim *et al*. ([@B38]). Transfection of miR-9 mimic alone lowered *ACOT7* mRNA and protein levels in DICER −/− cells (Figure [5A](#F5){ref-type="fig"}, left, lane 1 versus 2). MiR-9 levels were observed with positive and negative controls in DICER −/− cells (Figure [5A](#F5){ref-type="fig"}, right). Upon WIG1 depletion, ACOT7 protein levels evidently increased in DICER −/− cells, regardless of miR-9 transfection (Figure [5A](#F5){ref-type="fig"}). However, WIG1 did not suppress protein expression after AGO1, AGO2 or GW182 depletion in DICER −/− cells (Figure [5B](#F5){ref-type="fig"}). Altogether, we observed that WIG1 is indispensable to regulation of ACOT7 translation in an miRNA-independent manner in DICER −/− cells.

![Effects of WIG1 on ACOT7 mRNA and protein levels in human HCT116 DICER knockout (−/−) cell line. (**A**) WIG depletion induces upregulation of ACOT7 protein levels without alteration of mRNA levels, regardless of miR-9, in DICER −/− cells. Cells were harvested at 2 days after miR-9 transfection and subjected to western blot analysis. RT-qPCR analysis was used to quantify specific RNA levels. Let-7a and miR-451a were used as positive and negative controls for DICER-dependent miRNA-maturation products, respectively. (**B**) WIG1 tethering in the absence of AGO1, AGO2 or GW182 induces translational suppression in DICER −/− cells. pFL-8BS reporters in combination with pMS2-HA plasmids were transfected in AGO1, AGO2 or GW182 Si-transfected DICER −/− cells. Two days after transfection, cell lysates analyzed with western blotting and RT-qPCR. Translation rate was measured as the ratio of FL protein to mRNA. HCT116 parental cells were used as a positive control regarding DICER −/− cells. Data are represented as the means ± SD from three independent experiments. \*\**P* \< 0.01; ^\#^*P* \> 0.05.](gkx307fig5){#F5}

To identify which translation step is regulated by the WIG1--AGO2--GW182 complex, we generated several 5'UTR reporter constructs with different internal ribosome entry sites (IRESs) (Figure [6A](#F6){ref-type="fig"}). The cricket paralysis virus (CrPV) IRES requires no initiation factor, binds directly to ribosomal subunits and promotes elongation, whereas the encephalomyocarditis virus (EMCV) IRES requires all initiation factors apart from eIF4E ([@B56]). Furthermore, a hairpin structure upstream of each IRES blocks initiation of ribosomes at the cap to ensure translational initiation only at the IRES ([@B57],[@B58]). MCF7 cells were transfected with each reporter construct containing WIG1 Si, after which mRNA decay and translational efficiency were evaluated. Stabilization of EMCV IRES- and CrPV IRES-ACOT7-3**΄**UTR-Wt reporter mRNAs was observed in WIG1-depleted cells (Figure [6B](#F6){ref-type="fig"}, top). However, in contrast to cap- and EMCV IRES-dependent translational efficiencies, CrPV IRES-dependent translational efficiency was not elevated in WIG1-depleted cells (Figure [6B](#F6){ref-type="fig"}, bottom). This indicates that WIG1-mediated translational repression was not dependent on elongation blockage, ribosome drop-off or polypeptide degradation.

![WIG1 prevents eIF5B assembly during translational initiation of 60S ribosomal subunit joining via AGO2-GW182 recruitment under miRNA deficiency. (**A**) Schematic representations of IRES constructs encoding *FL* with *ACOT7* mRNA 3΄UTR. pFL-EV was used as a normalization control. (**B**) WIG1 suppresses translational initiation in the ACOT7-3΄UTR. MCF7 cells were transfected with WIG1 Si and pFL-ACOT7-3΄UTR-Wt, pEMCV-FL-ACOT7-3΄UTR-Wt or pCrPV-FL-ACOT7-3΄UTR-Wt in combination with pRL-CMV reference plasmid. Cells were harvested 24 h after transfection, and *FL* mRNA and (normalization control) *RL* mRNA were quantified by RT-qPCR analysis (top). Normalized level of each *IRES reporter* mRNA in the presence of each Con Si was set as 1. Translation rates were calculated as explained in Figure [4A](#F4){ref-type="fig"}. FL protein levels (FL activity) were normalized to RL levels (RL activity) (bottom); normalized levels of FL/RL activity in the presence of Con Si were set as 1. (**C**) MiR-9 is not required for WIG1-mediated translational initiation of *ACOT7* mRNA. MCF7 cells were transfected with WIG1 Si and pFL-ACOT7-3΄UTR-Mut, pEMCV-FL-ACOT7-3΄UTR-Mut or pCrPV-FL-ACOT7-3΄UTR-Mut in combination with pRL-CMV reference plasmid. Cells were harvested 24 h after transfection and *FL* mRNA and *RL* mRNA (for normalization) were quantified RT-qPCR (top). Normalized levels of each *IRES reporter* mRNA in the presence of each Con Si was set as 1. Translation rate was determined as the ratio of normalized FL protein to *FL* mRNA (as defined in Figure [4A](#F4){ref-type="fig"}); normalized level of FL activity in the presence of Con Si was defined as 1. Data are represented as the means ± SD from three independent experiments. \*\**P* \< 0.01. (**D**) RNA-independent interaction between WIG1 and eIF5B. HEK 293T cell lysates were obtained from WIG1-overexpressing HEK 293T cells. After immunoprecipitation using anti-Flag M2 affinity gel, proteins in the IP material were detected by western blot analysis (top). RT-qPCR detection of *Actin* mRNA was performed to assess completion of RNase A digestion (bottom). (**E**) EIF5B was preferentially recruited to WIG1-target mRNAs and specifically associates with AGO2-GW182. After transfection of HEK 293T cells with either AGO2 Si or GW182 Si and subsequent transfection with p3xFlag-WIG1, anti-Flag was used for immunoprecipitation, and the indicated proteins were detected by immunoblotting.](gkx307fig6){#F6}

To test whether or not WIG1-mediated translational repression requires miRNA, we tested translational regulation of IRES-ACOT7-3΄UTR-Mut reporters under WIG1-depleted conditions (Figure [6C](#F6){ref-type="fig"}). In the absence of WIG1, we observed no difference between IRES-ACOT7-3΄UTR-Mut reporter mRNAs and cap-dependent ACOT7-Mut reporter mRNA (Figure [6C](#F6){ref-type="fig"}, top). Consistent with the above results (Figure [6B](#F6){ref-type="fig"}, bottom), translation of CrPV IRES reporter was unaffected by WIG1 depletion (Figure [6C](#F6){ref-type="fig"}, bottom). Next, we sought to identify which WIG1-interacting molecules might be involved in the translational initiation step. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS), we detected eIF5B as a novel WIG1-interacting protein ([Supplementary Figure S13A and B](#sup1){ref-type="supplementary-material"}). We confirmed that WIG1 and eIF5B interacted directly and were not tethered by RNA, as their association was insensitive to RNase A digestion (Figure [6D](#F6){ref-type="fig"}).

To assess the specificity of the WIG1--eIF5B interaction, we examined interactions under either AGO2- or GW182-depleted conditions. The WIG1--eIF5B interaction was not detected in Flag-WIG1 immunoprecipitates upon depletion of either AGO2 or GW182 (Figure [6E](#F6){ref-type="fig"}), indicating that eIF5B associated with WIG1 through the AGO2--GW182 interaction. Collectively, these data provide evidence that WIG1-mediated translational suppression occurs at the translational initiation step through binding of the WIG1--AGO2--GW182 complex with eIF5B, regardless of miRNA-mediated translational control.

WIG1-binding motifs identified by PAR-CLIP analysis are critical for translational suppression {#SEC3-4}
----------------------------------------------------------------------------------------------

To identify binding motifs of WIG1 on the ACOT7-3΄UTR, we conducted PAR-CLIP analysis using anti-WIG1 antibody. After RNase T1 digestion and separation of crosslinked WIG1--RNA complexes, we performed RNA sequencing analysis of RNA bound to WIG1 (Figure [7A](#F7){ref-type="fig"}). A list of the cluster sequences and three highest-scoring motifs identified from the WIG1 PAR-CLIP analysis are shown ([Supplementary Table S3](#sup1){ref-type="supplementary-material"} and Figure [7B](#F7){ref-type="fig"}).

![Identification of WIG1-binding sequence by PAR-CLIP analysis. (**A**) 5'-end ^32^P-labeled RNA-Flag-WIG1 immunoprecipitates were prepared from RNase T1-treated lysates in the presence or absence of 100 mM 4-thiouridine (4SU) photoactivatable nucleoside and crosslinked with UV 365 nm (right). Western blot analysis using anti-Flag antibody (left). (**B**) Representative RNA recognition elements (RREs) of the top three significantly enriched motifs derived from motif analysis of WIG1 PAR-CLIP. (**C**) Cloning strategy for disruption of putative WIG1 PAR-CLIP site on the 3**΄**UTR of *ACOT7* mRNA with secondary structure predicted by RNAfold software. ACOT7-3΄UTR-BS Mut lacking two putative WIG1-binding sites (BS) from the PAR-CLIP analysis was cloned into pcFLuc vector. Base-pairing probabilities are color-coded. (**D**) Deletion of putative WIG1-binding sites disrupts WIG1 binding to the ACOT7 3΄UTR. HEK 293T cells were transfected with either pcFLuc-ACOT7-3΄UTR-Wt or -BS-Mut in combination with p3xFlag-WIG1 and pRL-CMV as a reference plasmid. After RIP using anti-Flag antibody, western blot analysis was performed using anti-Flag antibody (top) and *RL* and *FL* mRNAs RNAs were analyzed by quantification of radiolabeled RT-PCR products using Quantity One software (bottom). The four leftmost lanes represent sequential 2-fold dilutions of RNA. pRL-CMV were used as a negative control. The relative ratio of RT-sqPCR intensity represents the mean ± SD from three independent experiments. (**E**) Relative translational efficiency of ACOT7-3΄UTR reporters in WIG1-depleted cells. Diagrams of reporter vectors encoding *ACOT7* mRNA 3΄UTR-BS-Mut with full-length FL coding region. pFL-EV or pFL-ACOT7-3**΄**UTR-Wt was used as normalization control or positive control, respectively. Two days after transfection of MCF7 cells with WIG1 Si and pFL-ACOT7-3΄UTR reporters (pFL-EV, -Wt, -BS Mut) and pRL-CMV reference plasmid, RNA was isolated and *FL* mRNA and *RL* mRNA (normalization control) quantified by RT-qPCR analysis (left). Protein levels were determined with luciferase activity assay (right), and translation rates were determined as explained in Figure [4A](#F4){ref-type="fig"}. \*\**P* \< 0.01.](gkx307fig7){#F7}

To investigate WIG1 binding to putative binding sequences from the PAR-CLIP analysis, we generated a reporter construct containing deletions of putative WIG1-binding sequences in the *ACOT7* 3΄UTR (pcFLuc-ACOT7-3΄UTR-BS Mut; Figure [7C](#F7){ref-type="fig"}). Physical interaction of WIG1 with *ACOT7-3΄UTR-Wt* reporter mRNA but not *ACOT7-3΄UTR-BS Mut* reporter mRNA was observed in WIG1 immunoprecipitates, (Figure [7D](#F7){ref-type="fig"}). In addition, reporter mRNA level and translational efficiency were enhanced in pFL-ACOT7-3΄UTR-BS Mut-transfected cells compared to ACOT7-3΄UTR-Wt reporter in Con Si-transfected cells (Figure [7E](#F7){ref-type="fig"}, lane 1 versus 2). In contrast, reporter mRNA level and translational efficiency were the same after WIG1 depletion in ACOT7-3΄UTR-Wt- and -BS Mut-transfected cells (Figure [7E](#F7){ref-type="fig"}, lane 3 versus 4), indicating that translation driven by ACOT7-3΄UTR- BS Mut was unaffected by WIG1 depression.

*ACOT7* mRNA and protein levels are tuned in a WIG1-dependent manner following irradiation {#SEC3-5}
------------------------------------------------------------------------------------------

Since WIG1 expression is induced by the transcription factor p53 ([@B59]), we examined molecular statuses of p53, WIG1 and ACOT7 under p53-activating conditions. Ionizing radiation (IR) triggered p53 accumulation, WIG1 induction and ACOT7 downregulation in a dose-dependent manner (Figure [8A](#F8){ref-type="fig"}). Upon depletion of WIG1 in irradiated cells, we failed to observe IR-induced downregulation of *ACOT7* mRNA and ACOT7 protein levels (Figure [8B](#F8){ref-type="fig"}, lane 2 versus 4). Furthermore, we observed that treatment with anti-miR-9 increased *ACOT7* mRNA levels regardless of IR treatment (Figure [8C](#F8){ref-type="fig"}, bottom, lane 2 versus 4); however, under such conditions, IR exposure did not affect ACOT7 protein level, potentially indicating an effect of translational suppression due to p53-mediated WIG1 induction (Figure [8C](#F8){ref-type="fig"}, top, lane 2 versus 4). These results indicate that WIG1 fine-tuned ACOT7 gene expression via miRNA-dependent and -independent mechanisms under stress conditions. Altogether, our findings indicate that WIG1 plays a role in mRNA silencing, as seen for *ACOT7* mRNA, via two alternative mechanisms depending on mRNA availability: (i) in the presence of miRNA, WIG1 mediates target *ACOT7* mRNA decay and (ii) in the absence of miRNA, WIG1 is involved in *ACOT7* mRNA translational suppression (Figure [8D](#F8){ref-type="fig"}).

![Regulation of *ACOT7* mRNA and protein levels in a WIG1-dependent manner following irradiation. (**A**) MCF7 cells were harvested after exposure to 2, 4 or 6 Gy of ionizing radiation (IR) and subjected to immunoblotting for detection of p53, WIG1 and ACOT7. (**B**) Cells were transfected with Con Si or WIG1 Si, exposed to 6 Gy of IR, incubated for 24 h and then harvested for immunoblot and RT-PCR analyses. (**C**) After transfection with anti-miR-9, MCF7 cells were exposed to IR and then harvested for immunoblot and RT-PCR analyses. Actin was used as an internal control (A--C). Each bar in the graphs represents the mean ± SD compared to control cells from three independent experiments (B and C). \**P* \< 0.05; \*\**P* \< 0.01; ^\#^*P* \> 0.05. (**D**) Proposed model for novel dual role of WIG1: miRNA-dependent mRNA decay and miRNA-independent translational suppression. RNA-binding protein WIG1 is a novel dual repressor of gene silencing. WIG1 regulates target mRNA stability in an miRNA-dependent manner and suppresses translational initiation in an miRNA-independent manner.](gkx307fig8){#F8}

DISCUSSION {#SEC4}
==========

In the present study, we identified *ACOT7* mRNA as a novel WIG1 target using different RNA--protein assays. *ACOT7* mRNA expression was regulated by miR-9-mediated decay in a WIG1-dependent manner. Interestingly, *ACOT7* expression was also regulated in an miRNA-independent manner via the WIG1--AGO2--GW182 complex, which suppressed ACOT7 translation. In this paradigm, WIG1 suppressed initiation of translation by associating with the general translation initiation factor eIF5B. Furthermore, we identified WIG1 putative binding RNA motifs using PAR-CLIP and confirmed the critical role of these motifs in the regulation of ACOT7 gene silencing by WIG1.

Importantly, miRNA-mediated gene regulation fundamentally affects various cell functions ([@B9]). Key molecular events such as translational inhibition, deadenylation and mRNA decay are primarily coupled with miRNA mediated-mRNA silencing ([@B10]). MiRNA-mediated mRNA repression is triggered through molecular interactions between miRNA and the target mRNA 3΄UTR. However, recent experiments revealed that extensive AGO-associated mRNAs lack seed complementarity with miRNAs ([@B15],[@B18],[@B19]), and AGO--mRNA interactions also occur in the absence of miRNAs ([@B6]). Thus, there is a need for a new model to explain AGO recruitment of mRNA targets without miRNA guidance ([@B11]). A previous report revealed the novel function of AGO proteins as RBPs with specific sequence preferences ([@B18]). The RNA motif for AGO recognition was identified in a structurally accessible region from PAR-CLIP data. The motif established a role for AGO in recognition of its own targets without miRNA guidance. Other reports suggested that AGO proteins recruit mRNA targets by guiding RBPs without the guidance of miRNAs ([@B19],[@B49],[@B51]).

Accordingly, RBPs might help to recruit AGO to target RNAs via protein--protein interactions, after which AGO protein may facilitate gene silencing via interactions with proteins in the GW family ([@B46]). Furthermore, mature miRNAs are not produced in *DICER* knock-out mouse embryonic stem cells (ESCs) or *DICER*-deficient mouse embryonic fibroblasts; in both of these cases, AGO proteins can still associate with mRNA targets ([@B19]). In addition, in *Caenorhabditis elegans* and human cells, the RBP Pumilio (PUF) binds to AGO proteins on target mRNAs and the PUF-AGO protein and eukaryotic elongation factor 1α (eEF1A) complex represses translation elongation *in vitro* ([@B49]). In *Drosophila melanogaster*, the RBP Smaug recruits AGO1 to mRNAs independently of miRNAs and causes the target mRNA *nanos* to silence gene expression ([@B51]). Despite the fact that AGO proteins are recruited by RBPs to mRNAs in an miRNA-independent manner, it would be difficult to demonstrate that recruitment of AGOs is directly involved in RBP-mediated mRNA translational inhibition. Whether or not miRNAs bind to AGOs also remains unclear in this model.

We observed that WIG1-dependent AGO2 targeting triggers miRNA-mediated mRNA decay. In addition, we observed that WIG1 facilitates AGO2 binding to target mRNA independent of the presence of miRNA, ultimately leading to translation repression via formation of the WIG1--AGO2--GW182--eIF5B complex. The essential translation factor eIF5B assists the 60S ribosomal subunit joining in translation initiation ([@B60],[@B61]). We observed that the WIG1--AGO2--GW182--eIF5B complex was abrogated and that translational inhibition was rescued upon either AGO2 or GW182 depletion. These results support the notion that the WIG1--AGO2 interaction is critical for WIG1-mediated translational inhibition. Our results strongly support a model in which RBPs guide the recruitment of AGO to mRNA through protein--protein interactions independently of miRNA. The contribution of WIG1 to target mRNA silencing may, therefore, be distinct and more intractable than miRNA-mediated mRNA silencing; however, if no miRNAs are available or the miRNA processing pathway is defective, WIG1 may adopt an alternative pathway in order to fine-tune gene silencing. In fact, this dual property may be evolutionarily beneficial for regulation of gene expression to avoid detrimental cellular outcomes resulting from abnormal gene expression. Collectively, our findings suggest that WIG1 is a novel dual repressor of gene silencing that regulates target mRNA stability in an miRNA-dependent manner and suppresses translational initiation in an miRNA-independent manner.

WIG1 is a p53-inducible RNA-binding zinc-finger protein identified in almost all species and cell types ([@B59],[@B62],[@B63]). Several studies reported that WIG1 is involved in cell cycle arrest and cell death through stability regulation of mRNAs such as p53, N-myc, FAS and 14-3-3σ ([@B64]--[@B66]). Our previous work showed that WIG1 knockdown leads to cellular senescence by controlling p21 mRNA stability ([@B36]). We provided evidence that WIG1 plays a critical role in tumor progression in a murine xenograft model and human lung cancer tissues. Other study revealed the role of WIG1 in the maintenance of ESC through genome-wide RNAi screening ([@B67]). Another group recently showed that WIG1 is involved in the pathophysiology of Huntington\'s disease ([@B68]). WIG1 preferentially increases stability of mutant Huntingtin transcripts through higher affinity binding to mutant than normal counterparts. Therefore, these findings suggest that WIG1 could be a promising target molecule in relation to clinical applications.
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